[HTML][HTML] Do reimbursement recommendations by the Canadian Agency for Drugs and Technology in Health translate into coverage decisions for orphan drugs in the …
AM Fontrier, P Kanavos - Value in Health, 2023 - Elsevier
Objectives Unlike other high-income countries, Canada has no national policy for drugs
treating rare diseases (orphan drugs). Nevertheless, in 2022, the Canadian government …
treating rare diseases (orphan drugs). Nevertheless, in 2022, the Canadian government …
Orphan drugs approved in Canada: health technology assessment, price negotiation, and government formulary listing
NSB Rawson, J Adams - Expert Opinion on Orphan Drugs, 2024 - Taylor & Francis
ABSTRACT Background The US Food and Drug Administration (FDA) and European
Medicines Agency (EMA) have incentives to stimulate the development and marketing of …
Medicines Agency (EMA) have incentives to stimulate the development and marketing of …
